Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434982![]() (US10584104, Compound of Example 51) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434983![]() (US10584104, Compound of Example 52) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434973![]() (US10584104, Compound of Example 10) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434978![]() (US10584104, Compound of Example 38) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434970![]() (US10584104, Compound of Example 2) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 193 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434969![]() (US10584104, Compound of Example 1) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 201 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434979![]() (US10584104, Compound of Example 39) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 381 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434971![]() (US10584104, Compound of Example 5) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 418 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434972![]() (US10584104, Compound of Example 6) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434974![]() (US10584104, Compound of Example 11) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 484 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434981![]() (US10584104, Compound of Example 49) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 487 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434980![]() (US10584104, Compound of Example 48) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 512 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434976![]() (US10584104, Compound of Example 20) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 886 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434977![]() (US10584104, Compound of Example 25) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434975![]() (US10584104, Compound of Example 17) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434968![]() (US10584104, Compound B) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 1.81E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434966![]() (US10584104, Compound A) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Solute carrier family 22 member 12 (Homo sapiens (Human)) | BDBM434965![]() (US10584104, Compound lesinurad) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 7.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH CO., LTD. US Patent | Assay Description After trypsin digestion, the expression cells (HEK293) stably expressing URAT1 gene and mock cells were all inoculated into lysine-coated 24-well cul... | US Patent US10584104 (2020) BindingDB Entry DOI: 10.7270/Q2GH9MCX | |||||||||||
More data for this Ligand-Target Pair |